Overview


According to FutureWise analysis, the market for Orodispersible Tablets is expected to grow with a CAGR of 9.30% over the forecast period 2023-2031, and reach a market value of US$ 20.68 Billion by 2031. 

Orodispersible tablets are orally disintegrating (ODTs) and represent a specialized pharmaceutical dosage form designed to dissolve quickly in the mouth without needing water. These tablets are formulated to disintegrate within seconds to a minute after being placed on the tongue, allowing for easy administration, particularly for individuals who may have difficulty swallowing conventional tablets or capsules. This characteristic makes them highly convenient and portable, making them an ideal choice for patients of various age groups, including children, elderly individuals, and those with certain medical conditions.

Orodispersible tablets are typically engineered to have a pleasant taste and smooth texture to enhance patient acceptance. They are composed of active pharmaceutical ingredients (APIs) combined with excipients, auxiliary substances added to improve stability, enhance disintegration, and impart desirable characteristics like taste and mouthfeel. The formulation of ODTs involves a combination of ingredients like super disintegrants, sweeteners, flavorings, binders, and lubricants. Standard production techniques include direct compression, freeze-drying (lyophilization), and spray drying. Orodispersible tablets find applications in various medical scenarios, particularly in pediatrics, geriatrics, emergency medicine, and specific therapeutic areas like psychiatry and neurology. Their ease of use and effectiveness make them valuable to pharmaceutical options, providing a practical solution for patients with particular administration needs.

FutureWise Market Research has published a report that provides an insightful analysis of Orodispersible Tablets Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Orodispersible Tablets Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • AstraZeneca PLC
  • GlaxoSmithKline PLC
  • Novartis International AG
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Torrent Pharmaceuticals Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Eisai Co., Ltd.
  • Takeda Pharmaceutical Company Limited

(Note: The list of the major players will be updated with the latest market scenario and trends)

Orodispersible tablets provide a convenient and easy-to-administer option, particularly for individuals who have difficulty swallowing traditional tablets or capsules. This enhances patient compliance with prescribed medication regimens. The demand for orodispersible tablets is driven by the preference for user-friendly dosage forms, especially in populations like children, elderly individuals, and patients with certain medical conditions. Orodispersible tablets cater to paediatric and geriatric patients who may struggle with conventional oral medication forms. They offer a more accessible and palatable option for these demographics.  The specific needs of these patient populations contribute significantly to the growth of the orodispersible tablets market.  In emergencies where immediate medication administration is crucial, orodispersible tablets offer a rapid and convenient option, as they do not require water for ingestion.  Orodispersible tablets are critical in emergency medicine and situations where quick intervention is essential.

However, formulating orodispersible tablets with the right combination of active ingredients and excipients can be complex. Ensuring stability, especially for moisture-sensitive drugs, can be a challenge.  Formulation complexities and stability concerns may hinder the development and availability of certain medications in orodispersible tablet form.: Regulatory bodies have specific requirements for orodispersible tablets, including disintegration time and quality standards. Meeting these criteria can pose challenges for manufacturers and hinder the market.

By Drug Class

  • Analgesics
  • Antiemetics
  • Antipsychotics
  • Anti-inflammatory Drugs
  • Sedatives/Hypnotics
  • Antihypertensives
  • Others

By Disease Indication

  • Central Nervous System Disorders
  • Gastrointestinal Disorders
  • Cardiovascular Disorders
  • Respiratory Disorders
  • Allergy and Asthma
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Age Group

  • Pediatric Patients
  • Adult Patients
  • Geriatric Patients

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings

By Technology

  • Lyophilization
  • Tablet Molding
  • Spray Drying
  • Sublimation
  • Others

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the presence of established pharmaceutical companies, a robust healthcare infrastructure, increased healthcare spending, an increasing prevalence of chronic diseases, a rising geriatric population, and a growing focus on patient-centered care. Conversely, the European region is poised for substantial expansion in the forecast period because of advantageous reimbursement policies, a robustly established healthcare system, and a high incidence of chronic illnesses. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Orodispersible Tablets Market By Drug Class, By Disease Indication, By Distribution Channel, By Age Group, By End User, By Technology, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1. Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2. Primary Data
              1.2.1. Key Data from Primary Sources
        3. Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Orodispersible Tablets Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Orodispersible Tablets Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Orodispersible Tablets Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Orodispersible Tablets Market, By Drug Class Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Analgesics
        2. Antiemetics
        3. Antipsychotics
        4. Anti-inflammatory Drugs
        5. Sedatives/Hypnotics
        6. Antihypertensives
        7. Others

  • 8.  Orodispersible Tablets Market, By Disease Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Central Nervous System Disorders
        2. Gastrointestinal Disorders
        3. Cardiovascular Disorders
        4. Respiratory Disorders
        5. Allergy and Asthma
        6. Others

  • 9.  Orodispersible Tablets Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies

  • 10.  Orodispersible Tablets Market, By Age Group Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pediatric Patients
        2. Adult Patients
        3. Geriatric Patients

  • 11.  Orodispersible Tablets Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Ambulatory Surgical Centers
        4. Homecare Settings

  • 12.  Orodispersible Tablets Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Lyophilization
        2. Tablet Molding
        3. Spray Drying
        4. Sublimation
        5. Others

  • 13.  North America Orodispersible Tablets Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 14.  Latin America Orodispersible Tablets Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 15.  Europe Orodispersible Tablets Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 16.  Asia Pacific Orodispersible Tablets Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 17.  Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 18.  Market Share Analysis and Competitive Landscape
    •     1. Global Landscape - Key Players, Revenue and Presence
          2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
          3. Global Emerging Companies
          4. North America - Market Share Analysis and Key Regional Players
          5. Europe - Market Share Analysis and Key Regional Players
          6. Asia Pacific - Market Share Analysis and Key Regional Players
          7. Global Key Player - Growth Matrix

  • 19.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    •   1. AstraZeneca PLC
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. GlaxoSmithKline PLC
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Novartis International AG
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Johnson & Johnson Services, Inc.
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Teva Pharmaceutical Industries Ltd.
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Merck & Co., Inc.
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Pfizer Inc.
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Cipla Limited
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Dr. Reddy's Laboratories Ltd.
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Sun Pharmaceutical Industries Ltd.
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. Lupin Pharmaceuticals, Inc.
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Torrent Pharmaceuticals Ltd.
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. F. Hoffmann-La Roche Ltd.
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview
        14. Eisai Co., Ltd.
           14.1. Company Overview
           14.2. Product Portfolio
           14.3. SWOT Analysis
           14.4. Financial Overview
           14.5. Strategic Overview
        15. Takeda Pharmaceutical Company Limited
           15.1. Company Overview
           15.2. Product Portfolio
           15.3. SWOT Analysis
           15.4. Financial Overview
           15.5. Strategic Overview

  • 20.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
            administrations
        5. The overall economic slowdown of the developing and developed nations

  • 21.  FutureWise SME Key Takeaway Points for Client
    •   

Partner

Our Clients